Clinical relevance of autophagic therapy in cancer: Investigating the current trends, challenges, and future prospects

References

• Levine B, Sinha S, Kroemer G. Bcl-2 family members: dual regulators of apoptosis and autophagy. Autophagy 2008;4:600–6
   PubMed Web of Science ®Google Scholar
• Gundara JS, Zhao J, Robinson BG, Sidhu SB. Oncophagy: harnessing regulation of autophagy in cancer therapy. Endocr Relat Cancer 2012;19:R281–95
   Google Scholar
• Hamaï A, Codogno P, Mehrpour M. Cancer stem cells and autophagy: facts and perspectives. J Cancer Stem Cell Res 2014;2:e1005
   Google Scholar
• Ojha R, Bhattacharyya S, Singh SK. Autophagy in cancer stem cells: a potential link between chemoresistance, recurrence, and metastasis. Biores Open Access 2015;4:97–108
   PubMed Web of Science ®Google Scholar
• Lin YH, Huang YC, Chen LH, Chu PM. Autophagy in cancer stem/progenitor cells. Cancer Chemother Pharmacol 2015;75:879–86
   PubMed Web of Science ®Google Scholar
• Ohsumi Y. Historical landmarks of autophagy research. Cell Res 2014;24:9–23
   PubMed Web of Science ®Google Scholar
• Jung CH, Ro SH, Cao J, et al. mTOR regulation of autophagy. FEBS Lett 2010;584:1287–95
   PubMed Web of Science ®Google Scholar
• Jung CH, Seo M, Otto NM, Kim DH. ULK1 inhibits the kinase activity of mTORC1 and cell proliferation. Autophagy 2011;7:1212–21
   PubMed Web of Science ®Google Scholar
• Jung CH, Jun CB, Ro SH, et al. ULK-Atg13-FIP200 complexes mediate mTOR signaling to the autophagy machinery. Mol Biol Cell 2009;20:1992–2003
   PubMed Web of Science ®Google Scholar
• Hosokawa N, Hara T, Kaizuka T, et al. Nutrient-dependent mTORC1 association with the ULK1-Atg13-FIP200 complex required for autophagy. Mol Biol Cell 2009;20:1981–91
   PubMed Web of Science ®Google Scholar
• Bhutia SK, Mukhopadhyay S, Sinha N, et al. Autophagy: cancer’s friend or foe? Adv Cancer Res 2013;118:61–95
   PubMed Web of Science ®Google Scholar
• Papinski D, Kraft C. Atg1 kinase organizes autophagosome formation by phosphorylating Atg9. Autophagy 2014;10:1338–40
   PubMed Web of Science ®Google Scholar
• Papinski D, Schuschnig M, Reiter W, et al. Early steps in autophagy depend on direct phosphorylation of Atg9 by the Atg1 kinase. Mol Cell 2014;53:471–83
   PubMed Web of Science ®Google Scholar
• Webber JL, Young AR, Tooze SA. Atg9 trafficking in Mammalian cells. Autophagy 2007;3:54–6
   PubMed Web of Science ®Google Scholar
• Petiot A, Ogier-Denis E, Blommaart EF, et al. Distinct classes of phosphatidylinositol 3′-kinases are involved in signaling pathways that control macroautophagy in HT-29 cells. J Biol Chem 2000;275:992–8
   PubMed Web of Science ®Google Scholar
• Kihara A, Kabeya Y, Ohsumi Y, Yoshimori T. Beclin-phosphatidylinositol 3-kinase complex functions at the trans-Golgi network. EMBO Rep 2001;2:330–5
   PubMed Web of Science ®Google Scholar
• Gozuacik D, Kimchi A. Autophagy and cell death. Curr Top Dev Biol 2007;78:217–45
   PubMed Web of Science ®Google Scholar
• Fan W, Nassiri A, Zhong Q. Autophagosome targeting and membrane curvature sensing by Barkor/Atg14(L). Proc Natl Acad Sci USA 2011;108:7769–74
   PubMed Web of Science ®Google Scholar
• Burman C, Ktistakis NT. Regulation of autophagy by phosphatidylinositol 3-phosphate. FEBS Lett 2010;584:1302–12
   PubMed Web of Science ®Google Scholar
• Funderburk SF, Wang QJ, Yue Z. The Beclin 1-VPS34 complex – at the crossroads of autophagy and beyond. Trends Cell Biol 2010;20:355–62
   PubMed Web of Science ®Google Scholar
• Russell RC, Tian Y, Yuan H, et al. ULK1 induces autophagy by phosphorylating Beclin-1 and activating VPS34 lipid kinase. Nat Cell Biol 2013;15:741–50
   PubMed Web of Science ®Google Scholar
• Kim YM, Jung CH, Seo M, et al. mTORC1 phosphorylates UVRAG to negatively regulate autophagosome and endosome maturation. Mol Cell 2015;57:207–18
   PubMed Web of Science ®Google Scholar
• Molejon MI, Ropolo A, Re AL, et al. The VMP1–Beclin 1 interaction regulates autophagy induction. Sci Rep 2013;3:1055
   PubMed Web of Science ®Google Scholar
• Noda T, Fujita N, Yoshimori T. The late stages of autophagy: how does the end begin? Cell Death Differ 2009;16:984–90
   PubMed Web of Science ®Google Scholar
• Puri C, Renna M, Bento CF, et al. ATG16L1 meets ATG9 in recycling endosomes: additional roles for the plasma membrane and endocytosis in autophagosome biogenesis. Autophagy 2014;10:182–4
   PubMed Web of Science ®Google Scholar
• Kanki T, Wang K, Cao Y, et al. Atg32 is a mitochondrial protein that confers selectivity during mitophagy. Dev Cell 2009;17:98–109
   PubMed Web of Science ®Google Scholar
• Moreau K, Puri C, Rubinsztein DC. Methods to analyze SNARE-dependent vesicular fusion events that regulate autophagosome biogenesis. Methods 2015;75:19–24
   PubMed Web of Science ®Google Scholar
• Itakura E, Mizushima N. Syntaxin 17: the autophagosomal SNARE. Autophagy 2013;9:917–9
   PubMed Web of Science ®Google Scholar
• Nair U, Jotwani A, Geng J, et al. SNARE proteins are required for macroautophagy. Cell 2011;146:290–302
   PubMed Web of Science ®Google Scholar
• Moreau K, Renna M, Rubinsztein DC. Connections between SNAREs and autophagy. Trends Biochem Sci 2013;38:57–63
   PubMed Web of Science ®Google Scholar
• Takáts S, Pircs K, Nagy P, et al. Interaction of the HOPS complex with Syntaxin 17 mediates autophagosome clearance in Drosophila. Mol Biol Cell 2014;25:1338–54
   PubMed Web of Science ®Google Scholar
• Yu L, McPhee CK, Zheng L, et al. Termination of autophagy and reformation of lysosomes regulated by mTOR. Nature 2010;465:942–6
   PubMed Web of Science ®Google Scholar
• Rong Y, Liu M, Ma L, et al. Clathrin and phosphatidylinositol-4,5-bisphosphate regulate autophagic lysosome reformation. Nat Cell Biol 2012;14:924–34
   PubMed Web of Science ®Google Scholar
• Liu Y, Shoji-Kawata S, Sumpter RM Jr, et al. Autosis is a Na+, K+-ATPase-regulated form of cell death triggered by autophagy-inducing peptides, starvation, and hypoxia-ischemia. Proc Natl Acad Sci USA 2013;110:20364–71
   PubMed Web of Science ®Google Scholar
• Ichimura Y, Waguri S, Sou YS, et al. Phosphorylation of p62 activates the Keap1-Nrf2 pathway during selective autophagy. Mol Cell 2013;51:618–31
   PubMed Web of Science ®Google Scholar
• Mathew R, Karp CM, Beaudoin B, et al. Autophagy suppresses tumorigenesis through elimination of p62. Cell 2009;137:1062–75
   PubMed Web of Science ®Google Scholar
• Mathew R, Kongara S, Beaudoin B, et al. Autophagy suppresses tumor progression by limiting chromosomal instability. Genes Dev 2007;21:1367–81
   PubMed Web of Science ®Google Scholar
• Kimmelman AC. The dynamic nature of autophagy in cancer. Genes Dev 2011;25:1999–2010
   PubMed Web of Science ®Google Scholar
• Ng TL, Leprivier G, Robertson MD, et al. The AMPK stress response pathway mediates anoikis resistance through inhibition of mTOR and suppression of protein synthesis. Cell Death Differ 2012;19:501–10
   PubMed Web of Science ®Google Scholar
• Tasdemir E, Maiuri MC, Galluzzi L, et al. Regulation of autophagy by cytoplasmic p53. Nat Cell Biol 2008;10:676–87
   PubMed Web of Science ®Google Scholar
• Guo JY, Karsli-Uzunbas G, Mathew R, et al. Autophagy suppresses progression of K-ras-induced lung tumors to oncocytomas and maintains lipid homeostasis. Genes Dev 2013;27:1447–61
   PubMed Web of Science ®Google Scholar
• Huo Y, Cai H, Teplova I, et al. Autophagy opposes p53-mediated tumor barrier to facilitate tumorigenesis in a model of PALB2-associated hereditary breast cancer. Cancer Discov 2013;3:894–907
   PubMed Web of Science ®Google Scholar
• Qu X, Yu J, Bhagat G, et al. Promotion of tumorigenesis by heterozygous disruption of the beclin 1 autophagy gene. J Clin Invest 2003;112:1809–20
   PubMed Web of Science ®Google Scholar
• Rosenfeldt MT, O’Prey J, Morton JP, et al. p53 status determines the role of autophagy in pancreatic tumour development. Nature 2013;504:296–300
   PubMed Web of Science ®Google Scholar
• Yang A, Kimmelman AC. Inhibition of autophagy attenuates pancreatic cancer growth independent of TP53/TRP53 status. Autophagy 2014;10:1683–4
   PubMed Web of Science ®Google Scholar
• Pavlides S, Tsirigos A, Migneco G, et al. The autophagic tumor stroma model of cancer: role of oxidative stress and ketone production in fueling tumor cell metabolism. Cell Cycle 2010;9:3485–505
   PubMed Web of Science ®Google Scholar
• Tang D, Kang R, Livesey KM, et al. High mobility group box 1 (HMGB1) activates an autophagic response to oxidative stress. Antioxid Redox Signal 2011;15:2185–95
   PubMed Web of Science ®Google Scholar
• Amaravadi RK, Yu D, Lum JJ, et al. Autophagy inhibition enhances therapy-induced apoptosis in a Myc-induced model of lymphoma. J Clin Invest 2007;117:326–36
   PubMed Web of Science ®Google Scholar
• Golden EB, Cho HY, Jahanian A, et al. Chloroquine enhances temozolomide cytotoxicity in malignant gliomas by blocking autophagy. Neurosurg Focus 2014;37:E12
   PubMed Web of Science ®Google Scholar
• Ma Y, Galluzzi L, Zitvogel L, Kroemer G. Autophagy and cellular immune responses. Immunity 2013;39:211–27
   PubMed Web of Science ®Google Scholar
• Kangwan N, Park JM, Kim EH, Hahm KB. Chemoquiescence for ideal cancer treatment and prevention: where are we now? J Cancer Prev 2014;19:89–6
   PubMedGoogle Scholar
• Nishikawa M, Miyake H, Liu B, Fujisawa M. Expression pattern of autophagy-related markers in non-metastatic clear cell renal cell carcinoma: association with disease recurrence following radical nephrectomy. J Cancer Res Clin Oncol 2015;141:1585–91
   PubMed Web of Science ®Google Scholar
• Torre LA, Bray F, Siegel RL, et al. Global cancer statistics, 2012. CA Cancer J Clin 2015;65:87–108
   PubMed Web of Science ®Google Scholar
• Can G, Ekiz HA, Baran Y. Imatinib induces autophagy through BECLIN-1 and ATG5 genes in chronic myeloid leukemia cells. Hematology 2011;16:95–9
   PubMed Web of Science ®Google Scholar
• Gupta A, Roy S, Lazar AJ, et al. Autophagy inhibition and antimalarials promote cell death in gastrointestinal stromal tumor (GIST). Proc Natl Acad Sci USA 2010;107:14333–8
   PubMed Web of Science ®Google Scholar
• Miselli F, Negri T, Gronchi A, et al. Is autophagy rather than apoptosis the regression driver in imatinib-treated gastrointestinal stromal tumors? Transl Oncol 2008;1:177–86
   PubMed Web of Science ®Google Scholar
• Le XF, Mao W, Lu Z, et al. Dasatinib induces autophagic cell death in human ovarian cancer. Cancer 2010;116:4980–90
   PubMed Web of Science ®Google Scholar
• Amrein L, Soulières D, Johnston JB, Aloyz R. p53 and autophagy contribute to dasatinib resistance in primary CLL lymphocytes. Leuk Res 2011;35:99–102
   PubMed Web of Science ®Google Scholar
• Lin CI, Whang EE, Lorch JH, Ruan DT. Autophagic activation potentiates the antiproliferative effects of tyrosine kinase inhibitors in medullary thyroid cancer. Surgery 2012;152:1142–9
   PubMed Web of Science ®Google Scholar
• Sorafenib makes headway on metastatic thyroid cancer. Cancer Discov 2013;3:OF2
   Google Scholar
• Fischer TD, Wang JH, Vlada A, et al. Role of autophagy in differential sensitivity of hepatocarcinoma cells to sorafenib. World J Hepatol 2014;6:752–8
   PubMedGoogle Scholar
• Muselaers CH, Stillebroer AB, Desar IM, et al. Tyrosine kinase inhibitor sorafenib decreases 111In-girentuximab uptake in patients with clear cell renal cell carcinoma. J Nucl Med 2014;55:242–7
   PubMed Web of Science ®Google Scholar
• Moy B, Goss PE. Lapatinib: current status and future directions in breast cancer. Oncologist 2006;11:1047–57
   PubMed Web of Science ®Google Scholar
• Zhu X, Wu L, Qiao H, et al. Autophagy stimulates apoptosis in HER2-overexpressing breast cancers treated by lapatinib. J Cell Biochem 2013;114:2643–53
   PubMed Web of Science ®Google Scholar
• Chen S, Li X, Feng J, et al. Autophagy facilitates the Lapatinib resistance of HER2 positive breast cancer cells. Med Hypotheses 2011;77:206–8
   PubMed Web of Science ®Google Scholar
• Tang Y, Hamed HA, Cruickshanks N, et al. Obatoclax and lapatinib interact to induce toxic autophagy through NOXA. Mol Pharmacol 2012;81:527–40
   PubMed Web of Science ®Google Scholar
• Martin AP, Mitchell C, Rahmani M, et al. Inhibition of MCL-1 enhances lapatinib toxicity and overcomes lapatinib resistance via BAK-dependent autophagy. Cancer Biol Ther 2009;8:2084–96
   PubMed Web of Science ®Google Scholar
• Bursch W, Ellinger A, Kienzl H, et al. Active cell death induced by the anti-estrogens tamoxifen and ICI 164 384 in human mammary carcinoma cells (MCF-7) in culture: the role of autophagy. Carcinogenesis 1996;17:1595–607
   PubMed Web of Science ®Google Scholar
• Nagelkerke A, Sieuwerts AM, Bussink J, et al. LAMP3 is involved in tamoxifen resistance in breast cancer cells through the modulation of autophagy. Endocr Relat Cancer 2014;21:101–12
   PubMed Web of Science ®Google Scholar
• Giannopoulou E, Antonacopoulou A, Matsouka P, Kalofonos HP. Autophagy: novel action of panitumumab in colon cancer. Anticancer Res 2009;29:5077–82
   PubMed Web of Science ®Google Scholar
• Turzanski J, Daniels I, Haynes AP. Involvement of macroautophagy in the caspase-independent killing of Burkitt lymphoma cell lines by rituximab. Br J Haematol 2009;145:137–40
   PubMed Web of Science ®Google Scholar
• Brem EA, Thudium K, Khubchandani S, et al. Distinct cellular and therapeutic effects of obatoclax in rituximab-sensitive and -resistant lymphomas. Br J Haematol 2011;153:599–611
   PubMed Web of Science ®Google Scholar
• Huang JJ, Zhu YJ, Lin TY, et al. Beclin 1 expression predicts favorable clinical outcome in patients with diffuse large B-cell lymphoma treated with R-CHOP. Hum Pathol 2011;42:1459–66
   PubMed Web of Science ®Google Scholar
• Guo GF, Jiang WQ, Zhang B, et al. Autophagy-related proteins Beclin-1 and LC3 predict cetuximab efficacy in advanced colorectal cancer. World J Gastroenterol 2011;17:4779–86
   PubMed Web of Science ®Google Scholar
• Li X, Fan Z. The epidermal growth factor receptor antibody cetuximab induces autophagy in cancer cells by downregulating HIF-1alpha and Bcl-2 and activating the beclin 1/hVps34 complex. Cancer Res 2010;70:5942–52
   Google Scholar
• Li X, Lu Y, Pan T, Fan Z. Roles of autophagy in cetuximab-mediated cancer therapy against EGFR. Autophagy 2010;6:1066–77
   PubMed Web of Science ®Google Scholar
• Selvakumaran M, Amaravadi RK, Vasilevskaya IA, O’Dwyer PJ. Autophagy inhibition sensitizes colon cancer cells to antiangiogenic and cytotoxic therapy. Clin Cancer Res 2013;19:2995–3007
   PubMed Web of Science ®Google Scholar
• Guo XL, Li D, Sun K, et al. Inhibition of autophagy enhances anticancer effects of bevacizumab in hepatocarcinoma. J Mol Med (Berl) 2013;91:473–83
   PubMed Web of Science ®Google Scholar
• van Delft MF, Wei AH, Mason KD, et al. The BH3 mimetic ABT-737 targets selective Bcl-2 proteins and efficiently induces apoptosis via Bak/Bax if Mcl-1 is neutralized. Cancer Cell 2006;10:389–99
   PubMed Web of Science ®Google Scholar
• Yang MC, Loh JK, Li YY, et al. Bcl2L12 with a BH3-like domain in regulating apoptosis and TMZ-induced autophagy: a prospective combination of ABT-737 and TMZ for treating glioma. Int J Oncol 2015;46:1304–16
   PubMed Web of Science ®Google Scholar
• Saleem A, Dvorzhinski D, Santanam U, et al. Effect of dual inhibition of apoptosis and autophagy in prostate cancer. Prostate 2012;72:1374–81
   PubMed Web of Science ®Google Scholar
• Hann CL, Daniel VC, Sugar EA, et al. Therapeutic efficacy of ABT-737, a selective inhibitor of BCL-2, in small cell lung cancer. Cancer Res 2008;68:2321–8
   PubMed Web of Science ®Google Scholar
• Zinn RL, Gardner EE, Dobromilskaya I, et al. Combination treatment with ABT-737 and chloroquine in preclinical models of small cell lung cancer. Mol Cancer 2013;12:16
   PubMed Web of Science ®Google Scholar
• Trisciuoglio D, Desideri M, Ciuffreda L, et al. Bcl-2 overexpression in melanoma cells increases tumor progression-associated properties and in vivo tumor growth. J Cell Physiol 2005;205:414–21
   PubMed Web of Science ®Google Scholar
• Trisciuoglio D, De Luca T, Desideri M, et al. Removal of the BH4 domain from Bcl-2 protein triggers an autophagic process that impairs tumor growth. Neoplasia 2013;15:315–27
   PubMed Web of Science ®Google Scholar
• Heidari N, Hicks MA, Harada H. GX15-070 (obatoclax) overcomes glucocorticoid resistance in acute lymphoblastic leukemia through induction of apoptosis and autophagy. Cell Death Dis 2010;1:e76
   PubMed Web of Science ®Google Scholar
• Gao P, Bauvy C, Souquère S, et al. The Bcl-2 homology domain 3 mimetic gossypol induces both Beclin 1-dependent and Beclin 1-independent cytoprotective autophagy in cancer cells. J Biol Chem 2010;285:25570–81
   PubMed Web of Science ®Google Scholar
• Hamaï A, Codogno P. New targets for acetylation in autophagy. Sci Signal 2012;5:pe29
   PubMed Web of Science ®Google Scholar
• Del Bufalo D, Desideri M, De Luca T, et al. Histone deacetylase inhibition synergistically enhances pemetrexed cytotoxicity through induction of apoptosis and autophagy in non-small cell lung cancer. Mol Cancer 2014;13:230
   PubMed Web of Science ®Google Scholar
• Dupéré-Richer D, Kinal M, Ménasché V, et al. Vorinostat-induced autophagy switches from a death-promoting to a cytoprotective signal to drive acquired resistance. Cell Death Dis 2013;4:e486
   PubMed Web of Science ®Google Scholar
• Rao R, Balusu R, Fiskus W, et al. Combination of pan-histone deacetylase inhibitor and autophagy inhibitor exerts superior efficacy against triple-negative human breast cancer cells. Mol Cancer Ther 2012;11:973–83
   PubMed Web of Science ®Google Scholar
• Fruman DA, Rommel C. PI3K and cancer: lessons, challenges and opportunities. Nat Rev Drug Discov 2014;13:140–56
   PubMed Web of Science ®Google Scholar
• Maira SM, Stauffer F, Brueggen J, et al. Identification and characterization of NVP-BEZ235, a new orally available dual phosphatidylinositol 3-kinase/mammalian target of rapamycin inhibitor with potent in vivo antitumor activity. Mol Cancer Ther 2008;7:1851–63
   PubMed Web of Science ®Google Scholar
• Li H, Jin X, Zhang Z, et al. Inhibition of autophagy enhances apoptosis induced by the PI3K/AKT/mTor inhibitor NVP-BEZ235 in renal cell carcinoma cells. Cell Biochem Funct 2013;31:427–33
   PubMed Web of Science ®Google Scholar
• Yothaisong S, Dokduang H, Techasen A, et al. Increased activation of PI3K/AKT signaling pathway is associated with cholangiocarcinoma metastasis and PI3K/mTOR inhibition presents a possible therapeutic strategy. Tumour Biol 2013;34:3637–48
   PubMed Web of Science ®Google Scholar
• Hong SW, Shin JS, Moon JH, et al. NVP-BEZ235, a dual PI3K/mTOR inhibitor, induces cell death through alternate routes in prostate cancer cells depending on the PTEN genotype. Apoptosis 2014;19:895–904
   PubMed Web of Science ®Google Scholar
• Mukherjee B, Tomimatsu N, Amancherla K, et al. The dual PI3K/mTOR inhibitor NVP-BEZ235 is a potent inhibitor of ATM- and DNA-PKCs-mediated DNA damage responses. Neoplasia 2012;14:34–43
   PubMed Web of Science ®Google Scholar
• Xing C, Zhu B, Liu H, et al. Class I phosphatidylinositol 3-kinase inhibitor LY294002 activates autophagy and induces apoptosis through p53 pathway in gastric cancer cell line SGC7901. Acta Biochim Biophys Sin (Shanghai) 2008;40:194–201
   PubMed Web of Science ®Google Scholar
• Yang ZJ, Chee CE, Huang S, Sinicrope FA. The role of autophagy in cancer: therapeutic implications. Mol Cancer Ther 2011;10:1533–41
   PubMed Web of Science ®Google Scholar
• Bagci-Onder T, Wakimoto H, Anderegg M, et al. A dual PI3K/mTOR inhibitor, PI-103, cooperates with stem cell-delivered TRAIL in experimental glioma models. Cancer Res 2011;71:154–63
   PubMed Web of Science ®Google Scholar
• Tong Y, Liu YY, You LS, Qian WB. Perifosine induces protective autophagy and upregulation of ATG5 in human chronic myelogenous leukemia cells in vitro. Acta Pharmacol Sin 2012;33:542–50
   PubMed Web of Science ®Google Scholar
• Evangelisti C, Ricci F, Tazzari P, et al. Preclinical testing of the Akt inhibitor triciribine in T-cell acute lymphoblastic leukemia. J Cell Physiol 2011;226:822–31
   PubMed Web of Science ®Google Scholar
• Sefton EC, Qiang W, Serna V, et al. MK-2206, an AKT inhibitor, promotes caspase-independent cell death and inhibits leiomyoma growth. Endocrinology 2013;154:4046–57
   PubMed Web of Science ®Google Scholar
• Shi WY, Xiao D, Wang L, et al. Therapeutic metformin/AMPK activation blocked lymphoma cell growth via inhibition of mTOR pathway and induction of autophagy. Cell Death Dis 2012;3:e275
   PubMed Web of Science ®Google Scholar
• Tseng CH. Metformin reduces thyroid cancer risk in Taiwanese patients with type 2 diabetes. PLoS One 2014;9:e109852
   PubMed Web of Science ®Google Scholar
• Tsai MJ, Yang CJ, Kung YT, et al. Metformin decreases lung cancer risk in diabetic patients in a dose-dependent manner. Lung Cancer 2014;86:137–43
   PubMed Web of Science ®Google Scholar
• Wang N, Pan W, Zhu M, et al. Fangchinoline induces autophagic cell death via p53/sestrin2/AMPK signalling in human hepatocellular carcinoma cells. Br J Pharmacol 2011;164:731–42
   PubMed Web of Science ®Google Scholar
• Ge J, Liu Y, Li Q, et al. Resveratrol induces apoptosis and autophagy in T-cell acute lymphoblastic leukemia cells by inhibiting Akt/mTOR and activating p38-MAPK. Biomed Environ Sci 2013;26:902–11
   PubMed Web of Science ®Google Scholar
• Bishayee A. Cancer prevention and treatment with resveratrol: from rodent studies to clinical trials. Cancer Prev Res (Phila) 2009;2:409–18
   PubMed Web of Science ®Google Scholar
• Ling LU, Tan KB, Lin H, Chiu GN. The role of reactive oxygen species and autophagy in safingol-induced cell death. Cell Death Dis 2011;2:e129
   PubMed Web of Science ®Google Scholar
• Yu HC, Lin CS, Tai WT, et al. Nilotinib induces autophagy in hepatocellular carcinoma through AMPK activation. J Biol Chem 2013;288:18249–59
   PubMed Web of Science ®Google Scholar
• Yang PM, Liu YL, Lin YC, et al. Inhibition of autophagy enhances anticancer effects of atorvastatin in digestive malignancies. Cancer Res 2010;70:7699–709
   PubMed Web of Science ®Google Scholar
• Bristol ML, Di X, Beckman MJ, et al. Dual functions of autophagy in the response of breast tumor cells to radiation: cytoprotective autophagy with radiation alone and cytotoxic autophagy in radiosensitization by vitamin D3. Autophagy 2012;8:739–53
   PubMed Web of Science ®Google Scholar
• Demasters G, Di X, Newsham I, et al. Potentiation of radiation sensitivity in breast tumor cells by the vitamin D3 analogue, EB 1089, through promotion of autophagy and interference with proliferative recovery. Mol Cancer Ther 2006;5:2786–97
   PubMed Web of Science ®Google Scholar
• Dando I, Donadelli M, Costanzo C, et al. Cannabinoids inhibit energetic metabolism and induce AMPK-dependent autophagy in pancreatic cancer cells. Cell Death Dis 2013;4:e664
   PubMed Web of Science ®Google Scholar
• Liu X, Chhipa RR, Nakano I, et al. The AMPK inhibitor Compound C is a potent AMPK-independent anti-glioma agent. Mol Cancer Ther 2014;13:596–605
   PubMed Web of Science ®Google Scholar
• Beer TM, Armstrong AJ, Rathkopf DEV, et al. Enzalutamide in metastatic prostate cancer before chemotherapy. N Engl J Med 2014;371:424–33
   PubMed Web of Science ®Google Scholar
• Nguyen HG, Yang JC, Kung HJ, et al. Targeting autophagy overcomes Enzalutamide resistance in castration-resistant prostate cancer cells and improves therapeutic response in a xenograft model. Oncogene 2014;33:4521–30
   PubMed Web of Science ®Google Scholar
• Arcella A, Biagioni F, Antonietta Oliva M, et al. Rapamycin inhibits the growth of glioblastoma. Brain Res 2013;1495:37–51
   PubMed Web of Science ®Google Scholar
• Korets SB, Musa F, Curtin J, et al. Dual mTORC1/2 inhibition in a preclinical xenograft tumor model of endometrial cancer. Gynecol Oncol 2013;132:468–73
   PubMed Web of Science ®Google Scholar
• Cai Y, Xia Q, Su Q, et al. mTOR inhibitor RAD001 (everolimus) induces apoptotic, not autophagic cell death, in human nasopharyngeal carcinoma cells. Int J Mol Med 2013;31:904–12
   PubMed Web of Science ®Google Scholar
• Witzig TE, Geyer SM, Ghobrial I, et al. Phase II trial of single-agent temsirolimus (CCI-779) for relapsed mantle cell lymphoma. J Clin Oncol 2005;23:5347–56
   PubMed Web of Science ®Google Scholar
• Galimberti S, Petrini M. Temsirolimus in the treatment of relapsed and/or refractory mantle cell lymphoma. Cancer Manag Res 2010;2:181–9
   PubMedGoogle Scholar
• Chresta CM, Davies BR, Hickson I, et al. AZD8055 is a potent, selective, and orally bioavailable ATP-competitive mammalian target of rapamycin kinase inhibitor with in vitro and in vivo antitumor activity. Cancer Res 2010;70:288–98
   PubMed Web of Science ®Google Scholar
• Zheng B, Mao JH, Qian L, et al. Pre-clinical evaluation of AZD-2014, a novel mTORC1/2 dual inhibitor, against renal cell carcinoma. Cancer Lett 2015;357:468–75
   PubMed Web of Science ®Google Scholar
• Zou Z, Yuan Z, Zhang Q, et al. Aurora kinase A inhibition-induced autophagy triggers drug resistance in breast cancer cells. Autophagy 2012;8:1798–810
   PubMed Web of Science ®Google Scholar
• Francipane MG, Lagasse E. Selective targeting of human colon cancer stem-like cells by the mTOR inhibitor Torin-1. Oncotarget 2013;4:1948–62
   PubMed Web of Science ®Google Scholar
• Wang J, Wu GS. Role of autophagy in cisplatin resistance in ovarian cancer cells. J Biol Chem 2014;289:17163–73
   PubMed Web of Science ®Google Scholar
• Sun Y, Liu JH, Jin L, et al. Inhibition of Beclin 1 expression enhances cisplatin-induced apoptosis through a mitochondrial-dependent pathway in human ovarian cancer SKOV3/DDP cells. Oncol Res 2014;21:261–9
   PubMed Web of Science ®Google Scholar
• Xu Y, Yu H, Qin H, et al. Inhibition of autophagy enhances cisplatin cytotoxicity through endoplasmic reticulum stress in human cervical cancer cells. Cancer Lett 2012;314:232–43
   PubMed Web of Science ®Google Scholar
• Ding ZB, Hui B, Shi YH, et al. Autophagy activation in hepatocellular carcinoma contributes to the tolerance of oxaliplatin via reactive oxygen species modulation. Clin Cancer Res 2011;17:6229–38
   PubMed Web of Science ®Google Scholar
• Shi Y, Tang B, Yu PW, et al. Autophagy protects against oxaliplatin-induced cell death via ER stress and ROS in Caco-2 cells. PLoS One 2012;7:e51076
   Google Scholar
• Leng S, Hao Y, Du D, et al. Ursolic acid promotes cancer cell death by inducing Atg5-dependent autophagy. Int J Cancer 2013;133:2781–90
   PubMed Web of Science ®Google Scholar
• Shen W, Hu JA, Zheng JS. Mechanism of temozolomide-induced antitumour effects on glioma cells. J Int Med Res 2014;42:164–72
   PubMed Web of Science ®Google Scholar
• Friedman HS, Kerby T, Calvert H. Temozolomide and treatment of malignant glioma. Clin Cancer Res 2000;6:2585–97
   PubMed Web of Science ®Google Scholar
• Maede Y, Shimizu H, Fukushima T, et al. Differential and common DNA repair pathways for topoisomerase I- and II-targeted drugs in a genetic DT40 repair cell screen panel. Mol Cancer Ther 2014;13:214–20
   PubMed Web of Science ®Google Scholar
• Paillas S, Causse A, Marzi L, et al. MAPK14/p38α confers irinotecan resistance to TP53-defective cells by inducing survival autophagy. Autophagy 2012;8:1098–112
   PubMed Web of Science ®Google Scholar
• Akar U, Chaves-Reyez A, Barria M, et al. Silencing of Bcl-2 expression by small interfering RNA induces autophagic cell death in MCF-7 breast cancer cells. Autophagy 2008;4:669–79
   PubMed Web of Science ®Google Scholar
• Cosan D, Soyocak A, Tekedereli I, et al. Abstract 5109: doxorubicin-induced autophagy functions as a pro-survival pathway in breast cancer cells. In: Proceedings of the 101st Annual Meeting of the American Association for Cancer Research; 2010 Apr 17–21; Washington, DC. Philadelphia (PA): AACR. Cancer Res 2010;70:5109
   PubMed Web of Science ®Google Scholar
• Li DD, Sun T, Wu XQ, et al. The inhibition of autophagy sensitises colon cancer cells with wild-type p53 but not mutant p53 to topotecan treatment. PLoS One 2012;7:e45058
   Web of Science ®Google Scholar
• Biasoli D, Kahn SA, Cornélio TA, et al. Retinoblastoma protein regulates the crosstalk between autophagy and apoptosis, and favors glioblastoma resistance to etoposide. Cell Death Dis 2013;4:e767
   Google Scholar
• Pan X, Zhang X, Sun H, et al. Autophagy inhibition promotes 5-fluorouraci-induced apoptosis by stimulating ROS formation in human non-small cell lung cancer A549 cells. PLoS One 2013;8:e56679
   PubMed Web of Science ®Google Scholar
• Liang X, Tang J, Liang Y, et al. Suppression of autophagy by chloroquine sensitizes 5-fluorouracil-mediated cell death in gallbladder carcinoma cells. Cell Biosci 2014;4:10
   PubMed Web of Science ®Google Scholar
• Jia L, Gopinathan G, Sukumar JT, Gribben JG. Blocking autophagy prevents bortezomib-induced NF-κB activation by reducing I-κBα degradation in lymphoma cells. PLoS One 2012;7:e32584
   PubMed Web of Science ®Google Scholar
• Zhang X, Li W, Wang C, et al. Inhibition of autophagy enhances apoptosis induced by proteasome inhibitor bortezomib in human glioblastoma U87 and U251 cells. Mol Cell Biochem 2014;385:265–75
   PubMed Web of Science ®Google Scholar
• Vogl DT, Stadtmauer EA, Tan KS, et al. Combined autophagy and proteasome inhibition: a phase 1 trial of hydroxychloroquine and bortezomib in patients with relapsed/refractory myeloma. Autophagy 2014;10:1380–90
   PubMed Web of Science ®Google Scholar
• Zhu K, Dunner K Jr, McConkey DJ. Proteasome inhibitors activate autophagy as a cytoprotective response in human prostate cancer cells. Oncogene 2010;29:451–62
   PubMed Web of Science ®Google Scholar
• Mukubou H, Tsujimura T, Sasaki R, Ku Y. The role of autophagy in the treatment of pancreatic cancer with gemcitabine and ionizing radiation. Int J Oncol 2010;37:821–8
   PubMed Web of Science ®Google Scholar
• Albert JM, Cao C, Kim KW, et al. Inhibition of poly(ADP-ribose) polymerase enhances cell death and improves tumor growth delay in irradiated lung cancer models. Clin Cancer Res 2007;13:3033–42
   PubMed Web of Science ®Google Scholar
• Pan J, Chen B, Su CH, et al. Autophagy induced by farnesyltransferase inhibitors in cancer cells. Cancer Biol Ther 2008;7:1679–84
   PubMed Web of Science ®Google Scholar
• Ji C, Zhang L, Cheng Y, et al. Induction of autophagy contributes to crizotinib resistance in ALK-positive lung cancer. Cancer Biol Ther 2014;15:570–7
   PubMed Web of Science ®Google Scholar
• Gills JJ, Lopiccolo J, Dennis PA. Nelfinavir, a new anti-cancer drug with pleiotropic effects and many paths to autophagy. Autophagy 2008;4:107–9
   PubMed Web of Science ®Google Scholar
• Xi G, Hu X, Wu B, et al. Autophagy inhibition promotes paclitaxel-induced apoptosis in cancer cells. Cancer Lett 2011;307:141–8
   PubMed Web of Science ®Google Scholar
• Turcotte S, Chan DA, Sutphin PD, et al. A molecule targeting VHL-deficient renal cell carcinoma that induces autophagy. Cancer Cell 2008;14:90–102
   PubMed Web of Science ®Google Scholar
• Xi H, Kurtoglu M, Liu H, et al. 2-Deoxy-d-glucose activates autophagy via endoplasmic reticulum stress rather than ATP depletion. Cancer Chemother Pharmacol 2011;67:899–910
   PubMed Web of Science ®Google Scholar
• Bhutia SK, Dash R, Das SK, et al. Mechanism of autophagy to apoptosis switch triggered in prostate cancer cells by antitumor cytokine melanoma differentiation-associated gene 7/interleukin-24. Cancer Res 2010;70:3667–76
   Google Scholar
• Bhutia SK, Kegelman TP, Das SK, et al. Astrocyte elevated gene-1 induces protective autophagy. Proc Natl Acad Sci USA 2010;107:22243–8
   PubMed Web of Science ®Google Scholar
• Li X, Xu HL, Liu YX, et al. Autophagy modulation as a target for anticancer drug discovery. Acta Pharmacol Sin 2013;34:612–24
   PubMed Web of Science ®Google Scholar
• Liu J, Xia H, Kim M, et al. Beclin1 controls the levels of p53 by regulating the deubiquitination activity of USP10 and USP13. Cell 2011;147:223–34
   PubMed Web of Science ®Google Scholar
• Carew JS, Espitia CM, Esquivel JA 2nd, et al. Lucanthone is a novel inhibitor of autophagy that induces cathepsin D-mediated apoptosis. J Biol Chem 2011;286:6602–13
   PubMed Web of Science ®Google Scholar
• Sotelo J, Briceño E, López-González MA. Adding chloroquine to conventional treatment for glioblastoma multiforme: a randomized, double-blind, placebo-controlled trial. Ann Intern Med 2006;144:337–43
   PubMed Web of Science ®Google Scholar
• Schonewolf CA, Mehta M, Schiff D, et al. Autophagy inhibition by chloroquine sensitizes HT-29 colorectal cancer cells to concurrent chemoradiation. World J Gastrointest Oncol 2014;6:74–82
   PubMedGoogle Scholar
• Maes H, Kuchnio A, Peric A, et al. Tumor vessel normalization by chloroquine independent of autophagy. Cancer Cell 2014;26:190–206
   PubMed Web of Science ®Google Scholar
• Sui X, Chen R, Wang Z, et al. Autophagy and chemotherapy resistance: a promising therapeutic target for cancer treatment. Cell Death Dis 2013;4:e838
   PubMed Web of Science ®Google Scholar
• Pellegrini P, Strambi A, Zipoli C, et al. Acidic extracellular pH neutralizes the autophagy-inhibiting activity of chloroquine: implications for cancer therapies. Autophagy 2014;10:562–71
   PubMed Web of Science ®Google Scholar
• Lotze MT, Maranchie J, Appleman L. Inhibiting autophagy: a novel approach for the treatment of renal cell carcinoma. Cancer J 2013;19:341–7
   PubMed Web of Science ®Google Scholar
• Helgason GV, Mukhopadhyay A, Karvela M, et al. Autophagy in chronic myeloid leukaemia: stem cell survival and implication in therapy. Curr Cancer Drug Targets 2013;13:724–34
   PubMed Web of Science ®Google Scholar
• Dragowska WH, Weppler SA, Wang JC, et al. Induction of autophagy is an early response to gefitinib and a potential therapeutic target in breast cancer. PLoS One 2013;8:e76503
   Google Scholar
• Amaravadi RK, Winkler JD. Lys05: a new lysosomal autophagy inhibitor. Autophagy 2012;8:1383–4
   PubMed Web of Science ®Google Scholar
• McAfee Q, Zhang Z, Samanta A, et al. Autophagy inhibitor Lys05 has single-agent antitumor activity and reproduces the phenotype of a genetic autophagy deficiency. Proc Natl Acad Sci USA 2012;109:8253–8
   PubMed Web of Science ®Google Scholar
• Mohapatra P, Preet R, Das D, et al. Quinacrine-mediated autophagy and apoptosis in colon cancer cells is through a p53- and p21-dependent mechanism. Oncol Res 2012;20:81–91
   PubMed Web of Science ®Google Scholar
• Wu YC, Wu WK, Li Y, et al. Inhibition of macroautophagy by bafilomycin A1 lowers proliferation and induces apoptosis in colon cancer cells. Biochem Biophys Res Commun 2009;382:451–6
   PubMed Web of Science ®Google Scholar
• Choi HS, Jeong EH, Lee TG, et al. Autophagy inhibition with monensin enhances cell cycle arrest and apoptosis induced by mTOR or epidermal growth factor receptor inhibitors in lung cancer cells. Tuberc Respir Dis (Seoul) 2013;75:9–17
   PubMedGoogle Scholar
• Tanida I, Minematsu-Ikeguchi N, Ueno T, Kominami E. Lysosomal turnover, but not a cellular level, of endogenous LC3 is a marker for autophagy. Autophagy 2005;1:84–91
   PubMed Web of Science ®Google Scholar
• Sato K, Tsuchihara K, Fujii S, et al. Autophagy is activated in colorectal cancer cells and contributes to the tolerance to nutrient deprivation. Cancer Res 2007;67:9677–84
   PubMed Web of Science ®Google Scholar
• Racoma IO, Meisen WH, Wang QE, et al. Thymoquinone inhibits autophagy and induces cathepsin-mediated, caspase-independent cell death in glioblastoma cells. PLoS One 2013;8:e72882
   Google Scholar
• Udelnow A, Kreyes A, Ellinger S, et al. Omeprazole inhibits proliferation and modulates autophagy in pancreatic cancer cells. PLoS One 2011;6:e20143
   PubMed Web of Science ®Google Scholar
• Ojha R, Singh SK, Bhattacharyya S, et al. Inhibition of grade dependent autophagy in urothelial carcinoma increases cell death under nutritional limiting condition and potentiates the cytotoxicity of chemotherapeutic agent. J Urol 2014;191:1889–98
   PubMed Web of Science ®Google Scholar
• Liu D, Yang Y, Liu Q, Wang J. Inhibition of autophagy by 3-MA potentiates cisplatin-induced apoptosis in esophageal squamous cell carcinoma cells. Med Oncol 2011;28:105–11
   PubMed Web of Science ®Google Scholar
• Li J, Hou N, Faried A, et al. Inhibition of autophagy by 3-MA enhances the effect of 5-FU-induced apoptosis in colon cancer cells. Ann Surg Oncol 2009;16:761–71
   PubMed Web of Science ®Google Scholar
• Hamaï A, Botti J, Mehrpour M, Codogno P. Autophagy and tumor cell metabolism.In: Mazurek S, Shoshan M., eds. Tumor Cell Metabolism, Switzerland: Springer, 2015:45–63
   Google Scholar
• Reyjal J, Cormier K, Turcotte S. Autophagy and cell death to target cancer cells: exploiting synthetic lethality as cancer therapies. Adv Exp Med Biol 2014;772:167–88
   PubMed Web of Science ®Google Scholar
• Choi KS. Autophagy and cancer. Exp Mol Med 2012;44:109–20
   PubMed Web of Science ®Google Scholar
• Wei A, Tan P. Limitations of targeted therapy with sorafenib in elderly high-risk myelodysplastic syndrome and acute myeloid leukemia. Leuk Lymphoma 2013;54:675–6
   PubMed Web of Science ®Google Scholar
• Chien AJ, Munster PN, Melisko ME, et al. Phase I dose-escalation study of 5-day intermittent oral lapatinib therapy in patients with human epidermal growth factor receptor 2-overexpressing breast cancer. J Clin Oncol 2014;32:1472–9
   PubMed Web of Science ®Google Scholar
• Schoenlein PV, Periyasamy-Thandavan S, Samaddar JS, et al. Autophagy facilitates the progression of ERalpha-positive breast cancer cells to antiestrogen resistance. Autophagy 2009;5:400–3
   PubMed Web of Science ®Google Scholar
• Anelli TF, Anelli A, Tran KN, et al. Tamoxifen administration is associated with a high rate of treatment-limiting symptoms in male breast cancer patients. Cancer 1994;74:74–7
   PubMed Web of Science ®Google Scholar
• Khurana A, Mitsis D, Kowlgi GN, et al. Atypical presentation of fever as hypersensitivity reaction to oxaliplatin. J Oncol Pharm Pract. [Epub ahead of print]. doi: 10.1177/1078155214558350
   Web of Science ®Google Scholar
• Ng CV. Hypersensitivity reactions to oxaliplatin in two Asian patients. Ann Pharmacother 2005;39:1114–18
   PubMed Web of Science ®Google Scholar
• Oliva CR, Nozell SE, Diers A, et al. Acquisition of temozolomide chemoresistance in gliomas leads to remodeling of mitochondrial electron transport chain. J Biol Chem 2010;285:39759–67
   PubMed Web of Science ®Google Scholar
• Gershanovich ML, Moiceenko VM, Orlova RV. Prevention of cardiotoxicity of doxorubicin (Adriamycin) using cardioxane (ICRF-187, dexrazoxane) in the combination chemotherapy of disseminated breast cancer. Vopr Onkol 1993;39:26–32
   PubMedGoogle Scholar
• Li S, Wang A, Jiang W, Guan Z. Pharmacokinetic characteristics and anticancer effects of 5-fluorouracil loaded nanoparticles. BMC Cancer 2008;8:103
   PubMed Web of Science ®Google Scholar
• Buac D, Shen M, Schmitt S, et al. From bortezomib to other inhibitors of the proteasome and beyond. Curr Pharm Des 2013;19:4025–38
   PubMed Web of Science ®Google Scholar
• McConkey DJ, Zhu K. Mechanisms of proteasome inhibitor action and resistance in cancer. Drug Resist Updat 2008;11:164–79
   PubMed Web of Science ®Google Scholar
• Mujtaba T, Dou QP. Advances in the understanding of mechanisms and therapeutic use of bortezomib. Discov Med 2011;12:471–80
   PubMed Web of Science ®Google Scholar
• Kimura T, Takabatake Y, Takahashi A, Isaka Y. Chloroquine in cancer therapy: a double-edged sword of autophagy. Cancer Res 2013;73:3–7
   PubMed Web of Science ®Google Scholar
• Komatsu M, Waguri S, Chiba T, et al. Loss of autophagy in the central nervous system causes neurodegeneration in mice. Nature 2006;441:880–4
   PubMed Web of Science ®Google Scholar
• Nakai A, Yamaguchi O, Takeda T, et al. The role of autophagy in cardiomyocytes in the basal state and in response to hemodynamic stress. Nat Med 2007;13:619–24
   PubMed Web of Science ®Google Scholar
• Mortensen M, Soilleux EJ, Djordjevic G, et al. The autophagy protein Atg7 is essential for hematopoietic stem cell maintenance. J Exp Med 2011;208:455–67
   PubMed Web of Science ®Google Scholar
• Janku F, McConkey DJ, Hong DS, Kurzrock R. Autophagy as a target for anticancer therapy. Nat Rev Clin Oncol 2011;8:528–39
   PubMed Web of Science ®Google Scholar
• Payen C, Monnin L, Pulce C, Descotes J. Bone marrow aplasia following acute poisoning with chloroquine-proguanil. Clin Toxicol (Phila) 2008;46:1085–7
   PubMed Web of Science ®Google Scholar
• Launay-Vacher V, Rey JB, Isnard-Bagnis C, et al. European Society of Clinical Pharmacy Special Interest Group on Cancer Care. Prevention of cisplatin nephrotoxicity: state of the art and recommendations from the European Society of Clinical Pharmacy Special Interest Group on Cancer Care. Cancer Chemother Pharmacol 2008;61:903–9
   PubMed Web of Science ®Google Scholar
• Rosenfeld MR, Grossman SA, Brem S, et al. Pharmacokinetic analysis and pharmacodynamic evidence of autophagy inhibition in patients with newly diagnosed glioblastoma treated on a phase I trial of hydroxychloroquine in combination with adjuvant temozolomide and radiation (ABTC 0603). J Clin Oncol 2010;28:15s
   Google Scholar
• Wolpin BM, Rubinson DA, Wang X, et al. Phase II and pharmacodynamic study of autophagy inhibition using hydroxychloroquine in patients with metastatic pancreatic adenocarcinoma. Oncologist 2014;19:637–8
   PubMed Web of Science ®Google Scholar
• Aryal B, Denison AT, Gonzalez Y, Rao VA. Autophagy-based protein biomarkers for in vivo detection of cardiotoxicity in the context of cancer therapy. In: Hayat MA, ed. Autophagy: Cancer, Other Pathologies, Inflammation, Immunity, Infection and Aging. Vol. 3. San Diego, CA: Academic Press, 2013:299–303
   Google Scholar
• Bristol ML, Emery SM, Maycotte P, et al. Autophagy inhibition for chemosensitization and radiosensitization in cancer: do the preclinical data support this therapeutic strategy? J Pharmacol Exp Ther 2013;344:544–52
   PubMed Web of Science ®Google Scholar
• Liang X, De Vera ME, Buchser WJ, et al. Inhibiting systemic autophagy during interleukin 2 immunotherapy promotes long-term tumor regression. Cancer Res 2012;72:2791–801
   PubMed Web of Science ®Google Scholar
• Wang N, Feng Y. Elaborating the role of natural products-induced autophagy in cancer treatment: achievements and artifacts in the state of the art. Biomed Res Int 2015;2015:934207
   PubMedGoogle Scholar
• Liu JL, Chen FF, Lung J, et al. Prognostic significance of p62/SQSTM1 subcellular localization and LC3B in oral squamous cell carcinoma. Br J Cancer 2014;111:944–54
   PubMed Web of Science ®Google Scholar
• Park JM, Huang S, Wu TT, et al. Prognostic impact of Beclin 1, p62/sequestosome 1 and LC3 protein expression in colon carcinomas from patients receiving 5-fluorouracil as adjuvant chemotherapy. Cancer Biol Ther 2013;14:100–7
   PubMed Web of Science ®Google Scholar
• Jung G, Roh J, Lee H, et al. Autophagic markers BECLIN 1 and LC3 are associated with prognosis of multiple myeloma. Acta Haematol 2015;134:17–24
   PubMed Web of Science ®Google Scholar
• Vander Heiden MG, Cantley LC, Thompson CB. Understanding the Warburg effect: the metabolic requirements of cell proliferation. Science 2009;324:1029–33
   PubMed Web of Science ®Google Scholar
• Zhao X, He Y, Chen H. Autophagic tumor stroma: mechanisms and roles in tumor growth and progression. Int J Cancer 2013;132:1–8
   PubMed Web of Science ®Google Scholar
• Martinez-Outschoorn UE, Lin Z, Trimmer C, et al. Cancer cells metabolically “fertilize” the tumor microenvironment with hydrogen peroxide, driving the Warburg effect: implications for PET imaging of human tumors. Cell Cycle 2011;10:2504–20
   PubMed Web of Science ®Google Scholar
• Mariño G, Salvador-Montoliu N, Fueyo A, et al. Tissue-specific autophagy alterations and increased tumorigenesis in mice deficient in Atg4C/autophagin-3. J Biol Chem 2007;282:18573–83
   PubMed Web of Science ®Google Scholar
• Green DR, Levine B. To be or not to be? How selective autophagy and cell death govern cell fate. Cell 2014;157:65–75
   PubMed Web of Science ®Google Scholar
• Aits S, Gustafsson L, Hallgren O, et al. HAMLET (human alpha-lactalbumin made lethal to tumor cells) triggers autophagic tumor cell death. Int J Cancer 2009;124:1008–19
   PubMed Web of Science ®Google Scholar
• Jing Z, Han W, Sui X, et al. Interaction of autophagy with microRNAs and their potential therapeutic implications in human cancers. Cancer Lett 2015;356:332–8
   PubMed Web of Science ®Google Scholar
• Chen Y, Huang J, Liu B. AutomiRDB: a web resource connecting microRNAs and autophagy in cancer. Apoptosis 2015;20:1016–17
   PubMed Web of Science ®Google Scholar
• Zhang X, Shi H, Lin S, et al. MicroRNA-216a enhances the radiosensitivity of pancreatic cancer cells by inhibiting beclin-1-mediated autophagy. Oncol Rep 2015;34:1557–64
   PubMed Web of Science ®Google Scholar
• Dai F, Zhang Y, Chen Y. Involvement of miR-29b signaling in the sensitivity to chemotherapy in patients with ovarian carcinoma. Hum Pathol 2014;45:1285–93
   PubMed Web of Science ®Google Scholar
• Xu L, Beckebaum S, Iacob S, et al. MicroRNA-101 inhibits human hepatocellular carcinoma progression through EZH2 downregulation and increased cytostatic drug sensitivity. J Hepatol 2014;60:590–8
   PubMed Web of Science ®Google Scholar
• Stiuso P, Potenza N, Lombardi A, et al. MicroRNA-423-5p promotes autophagy in cancer cells and is increased in serum from hepatocarcinoma patients treated with sorafenib. Mol Ther Nucleic Acids 2015;4:e233
   PubMedGoogle Scholar
• Abraham D, Jackson N, Gundara JS, et al. MicroRNA profiling of sporadic and hereditary medullary thyroid cancer identifies predictors of nodal metastasis, prognosis, and potential therapeutic targets. Clin Cancer Res 2011;17:4772–81
   PubMed Web of Science ®Google Scholar
• Li J, Fu H, Xu C, et al. miR-183 inhibits TGF-beta1-induced apoptosis by downregulation of PDCD4 expression in human hepatocellular carcinoma cells. BMC Cancer 2010;10:354
   PubMed Web of Science ®Google Scholar
• Sinha N, Mukhopadhyay S, Das DN, et al. Relevance of cancer initiating/stem cells in carcinogenesis and therapy resistance in oral cancer. Oral Oncol 2013;49:854–62
   PubMed Web of Science ®Google Scholar
• Cufí S, Vazquez-Martin A, Oliveras-Ferraros C, et al. Autophagy positively regulates the CD44(+) CD24(−/low) breast cancer stem-like phenotype. . Cell Cycle 2011;10:3871–85
   PubMed Web of Science ®Google Scholar
• Gong C, Bauvy C, Tonelli G, et al. Beclin 1 and autophagy are required for the tumorigenicity of breast cancer stem-like/progenitor cells. Oncogene 2013;32:2261–72, 2272e.1–11
   PubMed Web of Science ®Google Scholar
• Yue W, Hamaï A, Tonelli G, et al. Inhibition of the autophagic flux by salinomycin in breast cancer stem-like/progenitor cells interferes with their maintenance. Autophagy 2013;9:714–29
   PubMed Web of Science ®Google Scholar
• Wu S, Wang X, Chen J, Chen Y. Autophagy of cancer stem cells is involved with chemoresistance of colon cancer cells. Biochem Biophys Res Commun 2013;434:898–903
   PubMed Web of Science ®Google Scholar